Month: October 2013

The Effect of Patents on Drug Prices

The NYT has a good article on how patents enable drug companies to keep prices high – far higher than in other countries. For example, with the patent for the older oral contraceptive Loestrin 24Fe about to expire, the company

Posted in Economics, Health care, Intellectual Property